Conestoga Discovery Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Conestoga Discovery Fund Institutional Class CMIRX
- NAV / 1-Day Return $10.32 / +0.19 %
- Fund Size $5.6M
- Adjusted Expense Ratio 1.250%
- Net Expense Ratio 1.250%
- Fee Level: Distribution High
- Share Class Type Institutional
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $250,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 31%
Morningstar’s Analysis CMIRX
Will CMIRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Twist Bioscience Corp | 5.87 | 332,905 | Healthcare |
Mama's Creations Inc Common Stock | 4.89 | 277,695 | Consumer Defensive |
Palomar Holdings Inc | 4.43 | 251,353 | Financial Services |
BioLife Solutions Inc | 4.42 | 250,927 | Healthcare |
Digi International Inc | 4.25 | 240,932 | Technology |
Transcat Inc | 4.18 | 237,415 | Industrials |
CryoPort Inc | 4.16 | 236,144 | Industrials |
Willdan Group Inc | 3.90 | 221,282 | Industrials |
Alpha Teknova Inc | 3.71 | 210,202 | Healthcare |
Construction Partners Inc Class A | 3.56 | 202,099 | Industrials |